Diagnosing Intestinal Angioedema on MDCT: A Radiologist's Guide to Mimics of Acute Abdomen

 

Executive Clinical Summary

Recurrent acute abdominal pain without a clear etiology poses a diagnostic challenge in emergency departments and outpatient clinics. When conventional laboratory markers and physical examinations fail to yield a definitive diagnosis, radiologists and clinicians must consider non-mechanical, fluid-mediated causes of bowel wall thickening. Intestinal angioedema is a distinct, often underdiagnosed clinical entity characterized by localized, transient submucosal edema of the gastrointestinal tract. This condition can mimic acute surgical abdomen, leading to unnecessary exploratory laparotomies if imaging findings are misread. This article provides an in-depth analysis of the clinical presentation, multidetector computed tomography (MDCT) diagnostic features, underlying pathophysiology, differential diagnoses, and enterprise healthcare workflow integration for intestinal angioedema.

Key Clinical Questions

1. What are the characteristic MDCT imaging features that differentiate intestinal angioedema from acute infectious enteritis or bowel ischemia?

2. Why do patients with intestinal angioedema frequently present with severe acute abdominal pain yet exhibit unremarkable physical examinations and normal routine laboratory findings?

3. How can diagnostic algorithms prevent unnecessary surgical interventions in patients suffering from transient, self-limiting visceral edema?

4. What is the role of C1-esterase inhibitor evaluation in distinguishing hereditary versus acquired forms of angioedema affecting the gastrointestinal tract?

5. How can enterprise PACS/RIS integration and AI-assisted triage streamline the recognition of submucosal edema in emergency radiology workflows?

Introduction

Abdominal pain is one of the most common presenting complaints in acute care medicine, accounting for millions of emergency department visits annually. While the majority of cases stem from common etiologies such as acute appendicitis, acute cholecystitis, diverticulitis, or bowel obstruction, a subset of patients experience recurrent, debilitating abdominal pain that eludes standard diagnostic workups. In patients presenting with repeated episodes of severe abdominal pain accompanied by ascites and bowel wall thickening—particularly in the absence of cutaneous manifestations or known mechanical obstruction—intestinal angioedema must be considered. Recognizing the characteristic radiologic patterns on contrast-enhanced computed tomography (CT) is vital to avoid inappropriate surgical exploration and ensure timely, conservative management.

Clinical Hook

Imagine a patient in their early fifties presenting to the emergency department with excruciating, recurrent abdominal pain, nausea, and vomiting. Physical examination reveals mild, generalized abdominal tenderness without peritoneal signs, and routine blood tests show no acute leukocytosis or electrolyte abnormalities. Previous evaluations during past episodes attributed the symptoms to nonspecific gastroenteritis or functional bowel disorders. However, a contrast-enhanced abdominal CT scan reveals marked, contiguous thickening of the small bowel loops with mucosal hyperenhancement, prominent engorged mesenteric vessels (the "comb sign"), and moderate ascites. Within 48 to 72 hours, symptoms spontaneously resolve without surgical intervention. This classic clinical-radiologic dissociation is the hallmark of intestinal angioedema, a condition where mastering imaging biomarkers prevents the operating room.

Learning Objectives

By the end of this article, readers should be able to:

1. Recognize the characteristic MDCT imaging findings of intestinal angioedema, including submucosal edema and fluid accumulation.

2. Understand the underlying pathophysiology involving bradykinin-mediated vascular permeability and visceral angioedema.

3. Identify crucial differential diagnoses, such as ischemic enteritis, Crohn's disease, and infectious enterocolitis.

4. Determine the appropriate diagnostic evaluation pathway, including complement factor assays and medication history review.

5. Understand the clinical significance of avoiding unnecessary surgical exploration in transient, self-limiting visceral edema.

6. Recognize common diagnostic pitfalls in interpreting acute gastrointestinal wall thickening.

Anatomy Review

The gastrointestinal tract exhibits specific structural layers on cross-sectional imaging, particularly when evaluated with high-resolution, contrast-enhanced MDCT.

• Normal Small Bowel Wall: Under normal physiological distention, the wall of the jejunum and ileum measures less than 3 mm in thickness. It demonstrates a characteristic tri-laminar or uniform enhancement pattern following intravenous contrast administration.

• Submucosa: Rich in loose connective tissue and vascular plexuses, the submucosa is the primary site of fluid accumulation in angioedema. When vascular permeability increases, fluid extravasation into this layer causes pronounced thickening and low-attenuation halo formation.

• Mesenteric Vasculature: The jejunal and ileal branches of the superior mesenteric artery and vein supply the small bowel. In intestinal angioedema, engorgement of these vasa recta vessels creates the distinctive comb sign, mimicking inflammatory bowel disease or early ischemia.

• Peritoneal Cavity: The visceral and parietal peritoneum respond to acute fluid shifts by transudation, frequently resulting in moderate ascites that is readily visualized on cross-sectional imaging.

Figure 1. Normal versus edematous small bowel wall architecture demonstrating submucosal fluid accumulation.

Case Presentation

Patient Profile

• Age/Sex: Early 50s female.

• History: Recurrent episodes of severe abdominal pain, nausea, and abdominal distention over several months, with previous hospitalizations yielding inconclusive workups. No prior history of allergy, cutaneous urticaria, or facial swelling. No use of Angiotensin-Converting Enzyme (ACE) inhibitors.

• Symptoms: Acute onset of severe, cramping generalized abdominal pain accompanied by nausea and vomiting.

• Physical Examination: Mild generalized abdominal tenderness without guarding, rigidity, or rebound tenderness. Bowel sounds are typically normal or slightly hypoactive. No cutaneous rashes, lip swelling, or laryngeal stridor.

• Laboratory Findings: Complete blood count showing normal leukocyte count and hemoglobin. Serum electrolytes, amylase, lipase, and liver function tests within normal limits. C-reactive protein (CRP) mildly elevated or normal.

• Clinical Question: What is the underlying cause of recurrent acute abdominal pain with prominent small bowel thickening and ascites in the absence of surgical pathology?

• Imaging: Contrast-enhanced abdominal CT demonstrating diffuse wall thickening of the jejunum and ileum, marked submucosal edema (target sign), fluid-filled bowel loops, and moderate ascites.

• Pathology: Not applicable, as management is strictly conservative, avoiding biopsy or resection.

• Treatment: Supportive care, intravenous fluid resuscitation, and bowel rest. Evaluation for hereditary or acquired C1-esterase inhibitor deficiency.

• Final Diagnosis: Intestinal angioedema (visceral angioedema).

• Outcome: Complete resolution of symptoms and radiologic normalization within 48 to 72 hours of conservative management.

Figure 2. Contrast-enhanced axial CT scan

Pathophysiology

Intestinal angioedema is fundamentally driven by localized increases in vascular permeability mediated by vasoactive peptides, predominantly bradykinin.

• Bradykinin Pathway: Unlike histamine-mediated allergic reactions, bradykinin-mediated angioedema does not respond to antihistamines, glucocorticoids, or epinephrine. Bradykinin acts on B2 receptors on endothelial cells, causing rapid relaxation of smooth muscle, vasodilation, and widening of endothelial junctions.

• Visceral Localization: While cutaneous angioedema affects the skin and subcutaneous tissues of the face, lips, or extremities, visceral angioedema selectively targets the smooth muscle and submucosa of the gastrointestinal tract. The rich vascular network of the jejunum and ileum makes them particularly susceptible to sudden, profound fluid shifts.

• Edema Formation: As plasma transudes across the capillary endothelium into the interstitium, the submucosa swells dramatically. This leads to luminal narrowing, spastic contractions of the muscularis propria, and accumulation of protein-rich fluid within the peritoneal cavity (ascites). Because the process is transient, degradation of bradykinin by kininases naturally halts the cascade, explaining the spontaneous resolution seen within days.

Epidemiology

• Prevalence: Intestinal angioedema is an uncommon clinical entity, frequently underdiagnosed due to its transient nature and clinical mimicry of acute surgical abdomen.

• Demographics: It can occur across various age groups, with acquired forms often presenting in middle-aged or older adults, whereas hereditary forms manifest earlier in life with a positive family history.

• Associations: While commonly linked to hereditary angioedema (HAE due to C1-INH deficiency) or ACE inhibitor therapy, idiopathic and acquired C1-esterase inhibitor deficiencies (associated with lymphoproliferative disorders) represent crucial clinical subsets.

Clinical Presentation

Patients typically present with dramatic clinical manifestations that contrast sharply with objective physical findings:

• Abdominal Pain: Sudden onset, severe, colicky or constant, disproportionate to physical examination findings.

• Gastrointestinal Symptoms: Nausea, vomiting, profuse watery diarrhea, and abdominal distention.

• Absence of Cutaneous Signs: Crucially, many patients exhibit zero cutaneous involvement—no hives, lip swelling, or peripheral edema—making clinical suspicion entirely dependent on imaging and detailed medication/family history review.

Imaging Features

Computed Tomography (CT)

Contrast-enhanced MDCT is the gold standard for diagnosing intestinal angioedema. Key imaging features include:

• Bowel Wall Thickening: Marked, smooth, and symmetrical thickening of the small bowel loops (predominantly jejunum and ileum).

• Submucosal Edema (Target Sign): Pronounced low-attenuation edema within the submucosal layer, sandwiched between enhancing mucosa and serosa.

• Comb Sign: Prominent, engorged vasa recta supplying the affected bowel loops due to hyperemia and fluid redistribution.

• Ascites: Moderate to large amounts of high-attenuation fluid distributed within the peritoneal cavity and pelvic cul-de-sac.

• Mesenteric Edema: Hazy, increased attenuation of the mesenteric fat surrounding the involved bowel segments.

Radiologist Interpretation

Figure 3. Coronal MDCT reformatted image showing extensive involvement of jejunal loops and the comb sign (vascular engorgement)

Findings

Contrast-enhanced CT of the abdomen and pelvis demonstrates diffuse, continuous mural thickening involving multiple loops of the proximal and distal small bowel. The thickened bowel walls exhibit a distinct low-attenuation submucosal halo (target sign). There is prominent engorgement of the mesenteric vasa recta. Moderate free fluid is observed in the dependent peritoneal recesses and pelvis. There is no evidence of pneumoperitoneum, high-grade mechanical obstruction, focal bowel discontinuity, or solid organ laceration.

Impression

Marked small bowel wall thickening with extensive submucosal edema and moderate ascites, highly characteristic of intestinal angioedema. Recommend clinical correlation for medication history (ACE inhibitors) or complement factor evaluation (C4, C1-INH functional assay) to exclude hereditary or acquired angioedema.

Imaging Physics

• X-Ray Attenuation and Hounsfield Units (HU): MDCT relies on differential X-ray absorption measured in Hounsfield Units. Normal bowel wall soft tissue measures approximately 40–60 HU. In intestinal angioedema, the excessive accumulation of water and proteinaceous fluid in the submucosa lowers its attenuation, creating the characteristic hypodense halo compared to the enhancing mucosa (80–100 HU).

• Multiplanar Reformats (MPR): Isotropic voxel acquisitions allow high-resolution coronal and sagittal MPR reconstructions, enabling radiologists to trace long segments of affected bowel and evaluate mesenteric vascular engorgement without partial-volume averaging artifacts.

Differential Diagnosis

Diagnosis	Key Imaging Finding	Clinical Clue	Differentiating Point
Intestinal Angioedema	Smooth mural thickening, submucosal edema, comb sign, ascites	Recurrent pain, normal labs, no cutaneous signs	Rapid spontaneous resolution within 48–72 hours; normal follow-up imaging
Acute Mesenteric Ischemia	Focal or segmental wall thickening, pneumatosis intestinalis, portomesenteric gas	Cardiovascular risk factors, pain out of proportion	Arterial/venous occlusion on CT angiography; progressive clinical deterioration
Crohn’s Disease	Asymmetric wall thickening, mucosal ulceration, comb sign, fistula/stricture	Chronic diarrhea, weight loss, younger age	Chronic course, cobblestoning, fibrofatty proliferation
Infectious Enteritis	Mucosal hyperenhancement, prominent lymphadenopathy, fat stranding	Fever, acute diarrhea, leukocytosis	Positive stool cultures, self-limiting infectious history
Strangulated Obstruction	Closed-loop obstruction, beak sign, whirl sign, reduced wall enhancement	Acute vomiting, absolute constipation, prior surgery	Transition point with mechanical obstruction

Multimodal Imaging Comparison

Modality	Strength	Limitation	Best Clinical Question
MDCT with IV Contrast	Excellent spatial resolution, evaluates bowel wall, mesentery, and vasculature	Ionizing radiation, intravenous iodinated contrast risk	Is there acute bowel wall thickening, edema, or surgical perforation?
Abdominal Ultrasound	Non-invasive, no radiation, bedside availability	Highly operator-dependent, limited by bowel gas and obesity	Can we identify bowel wall stratification and peristalsis in real time?
MRI Enterography	High soft tissue contrast, no ionizing radiation	Long acquisition time, high cost, limited emergency availability	Is there chronic inflammatory activity or fibrosis without radiation exposure?
Plain Radiography	Rapid screening for free air or bowel obstruction	Low sensitivity for soft tissue and mucosal edema	Is there gross pneumoperitoneum or mechanical obstruction?

Imaging Diagnostic Algorithm

Figure 4. Clinical and radiologic diagnostic workflow for evaluating acute visceral edema.

Treatment

• Supportive Care: The cornerstone of management for acute intestinal angioedema is conservative care, including bowel rest, intravenous fluid resuscitation, and correction of electrolyte imbalances.

• Medication Review: Immediate discontinuation of offending agents such as ACE inhibitors if implicated.

• Specific Therapies: For acute attacks of hereditary angioedema (HAE) involving the viscera, specific targeted therapies include C1-esterase inhibitor concentrate, icatibant (a selective bradykinin B2 receptor antagonist), or ecallantide (a plasma kallikrein inhibitor). Fresh frozen plasma (FFP) can be utilized when specific agents are unavailable, though it carries a theoretical risk of worsening symptoms due to the provision of substrate.

• Surgical Avoidance: Exploratory laparotomy must be strictly avoided unless frank signs of perforation, infarction, or peritonitis develop.

Prognosis

• Clinical Outcome: Excellent for acute attacks, with complete clinical and radiologic resolution typically occurring within 48 to 72 hours of conservative management.

• Recurrence: Patients with idiopathic or hereditary forms may experience recurrent episodes unless underlying triggers are identified and prophylactic therapy (e.g., attenuated androgens or antifibrinolytics for HAE) is instituted.

• Complications: Misdiagnosis leading to unnecessary exploratory laparotomy represents the primary major morbidity associated with this condition.

Artificial Intelligence Perspective

Artificial intelligence (AI) and computer vision models hold significant promise in detecting subtle visceral edema on emergency CT scans.

• Convolutional Neural Networks (CNNs) & Vision Transformers (ViTs): Advanced deep learning architectures can be trained to segment small bowel loops and quantify mural attenuation differences in Hounsfield units.

• Automated Triage: AI algorithms integrated into the PACS can flag abnormal low-attenuation submucosal halos in patients presenting with acute abdominal pain, alerting emergency radiologists to consider non-surgical etiologies like angioedema before surgical consults are finalized.

• Multimodal Integration: Future foundation models combining EMR clinical notes (such as recurrent pain without leukocytosis) with imaging features will enhance diagnostic precision for rare mimics of acute abdomen.

AI Development Pipeline

• Training: Curating large-scale datasets of anonymized abdominal CT scans featuring verified cases of bowel wall edema, enteritis, and normal controls.

• Validation: Internal cross-validation utilizing multi-center DICOM datasets to ensure robust segmentation of bowel layers.

• External Validation: Testing model generalizability across diverse scanner vendors (Siemens, GE, Philips) and reconstruction protocols.

• Deployment & Monitoring: Integrating AI inference engines into enterprise PACS via DICOMweb standards, with continuous drift detection to monitor sensitivity and specificity in emergency care settings.

AI Failure Analysis

• False Positives: Severe infectious enteritis or early bowel ischemia may present with similar mural thickening and submucosal edema, leading AI to misclassify inflammatory or ischemic conditions as angioedema.

• Artifacts: Beam-hardening artifacts from patient motion or dense contrast material can obscure subtle submucosal halos.

• Clinical Context Blindness: Purely image-based AI models lack access to critical clinical metadata (e.g., absence of fever, medication history), underscoring the necessity of human radiologist oversight.

Enterprise Healthcare Workflow

Figure 5. Enterprise PACS, RIS, and AI orchestration pipeline for emergency abdominal imaging.

Enterprise AI Architecture

• Centralized AI Platform: Deployment of containerized AI models within a hospital's secure cloud or on-premises edge servers.

• Orchestration and Routing: Automatic routing of abdominal CT DICOM studies through an AI broker that triggers specialized bowel analysis algorithms when acute pain protocols are initiated.

• Interoperability: Seamless data exchange using HL7 FHIR standards to sync AI imaging findings with patient EMR allergy and medication profiles (e.g., verifying ACE inhibitor status).

• Cybersecurity & Governance: Strict adherence to HIPAA/GDPR standards, role-based access control, and comprehensive audit logging for all AI-assisted diagnostic recommendations.

Healthcare Economics

• Cost Avoidance: The primary economic benefit of diagnosing intestinal angioedema accurately on CT is the prevention of costly, invasive exploratory laparotomies, prolonged intensive care unit stays, and unnecessary surgical complications.

• Resource Optimization: Reducing emergency department length of stay and avoiding redundant diagnostic workups improves hospital throughput and operational efficiency.

• Return on Investment (ROI) Framework:

  $$\text{ROI} = \frac{\text{Financial Benefit (Surgical Cost Avoidance)} - \text{Total Cost of Ownership (IT, Licensing, Integration)}}{\text{Total Cost of Ownership}}$$

Regulatory Perspective

• Software as a Medical Device (SaMD): AI algorithms designed to analyze cross-sectional imaging for bowel pathology require stringent regulatory clearance (e.g., FDA 510(k) clearance or CE-MDR certification).

• Clinical Validation: Manufacturers must provide robust multi-reader clinical studies demonstrating that AI assistance improves radiologist diagnostic accuracy without increasing false-positive surgical referrals.

• Human Oversight: Regulatory frameworks mandate that AI outputs serve strictly as decision support tools, requiring final verification and sign-off by a board-certified radiologist.

Explainable AI

• Saliency Maps and Heatmaps: Gradient-weighted Class Activation Mapping (Grad-CAM) highlights the specific jejunal segments and submucosal layers that triggered the AI's classification of visceral edema.

• Confidence Scoring: Providing calibrated uncertainty metrics alongside imaging overlays helps clinicians gauge the reliability of the AI's differential diagnosis.

Future Precision Medicine

• Radiogenomics: Linking specific imaging phenotypes of bowel wall edema with genetic mutations in complement regulatory genes (e.g., SERPING1 mutations in hereditary angioedema).

• Digital Twins: Creating personalized physiological models of vascular permeability to predict individual patient response to targeted bradykinin receptor antagonists.

Expert Insights

Expert Insight 1 — Radiologist Perspective

Never dismiss symmetrical small bowel wall thickening with a prominent submucosal halo as simple "nonspecific enteritis" when the patient has zero fever, normal leukocytes, and agonizing pain. Look closely at the mesentery for comb signs and ascites.

Expert Insight 2 — Emergency Department Perspective

The greatest trap in acute abdominal pain is the mismatch between severe patient distress and a benign abdominal exam. When analgesics fail and physical signs are absent, order a contrast-enhanced CT promptly.

Expert Insight 3 — Gastroenterology Perspective

Always take a meticulous medication history specifically inquiring about ACE inhibitors, even if the patient has taken them for years without prior incident. Drug-induced angioedema can present insidiously.

Expert Insight 4 — Clinical Workflow Perspective

Radiology structured reporting templates should include explicit checkboxes for "submucosal edema," "comb sign," and "ascites" to prompt emergency physicians to consider non-mechanical etiologies.

Expert Insight 5 — AI Deployment Perspective

AI models trained on emergency CT datasets can dramatically reduce diagnostic turnaround times by flagging high-attenuation submucosal halos before formal attending review.

Expert Insight 6 — PACS/RIS Integration Perspective

Integrating automated EMR medication alerts directly into the PACS viewer enables radiologists to instantly correlate imaging findings with recent prescription changes.

Expert Insight 7 — Hospital CIO Perspective

Investing in enterprise imaging AI orchestration platforms streamlines specialty triage, reducing downstream costs associated with misdiagnosed acute surgical abdomens.

Expert Insight 8 — Hospital Health Economics Perspective

Avoiding a single unnecessary exploratory laparotomy through accurate initial CT interpretation saves thousands of dollars in direct surgical and inpatient costs.

Expert Insight 9 — Patient Journey Perspective

Timely diagnosis spares patients from enduring repeated painful abdominal crises, unnecessary exploratory surgeries, and months of diagnostic uncertainty.

Expert Insight 10 — Future Technology Perspective

The convergence of multimodal foundation models and automated DICOM analysis will soon enable real-time risk stratification for rare vascular and allergic abdominal emergencies.

Clinical Pearls

1. The Target Sign: A low-attenuation submucosal halo sandwiched between enhancing mucosa and serosa is the radiologic signature of edema.

2. Pain-Exam Mismatch: Severe, debilitating colicky pain with a soft, non-peritoneal abdomen strongly suggests a non-surgical, fluid-mediated etiology.

3. The Comb Sign: Engorged vasa recta reflect intense local hyperemia accompanying visceral edema.

4. Ascites on CT: Moderate free peritoneal fluid frequently accompanies acute intestinal angioedema due to transudation.

5. ACE Inhibitor Check: Always review outpatient medication lists for ACE inhibitors before assuming idiopathic disease.

6. Complement Testing: Evaluate C4, C1-INH protein, and C1-INH function during quiescent intervals to diagnose hereditary angioedema.

7. Spontaneous Resolution: True angioedematous bowel changes resolve completely within 48 to 72 hours without surgical intervention.

8. Avoid the Scalpel: Recognizing imaging features of angioedema prevents catastrophic, unnecessary exploratory laparotomies.

Common Diagnostic Pitfalls

• Mistaking Edema for Ischemia: Confusing transient submucosal edema with early arterial or venous occlusion, leading to unnecessary emergency revascularization or resection.

• Overlooking Medication History: Failing to ask about ACE inhibitor use, resulting in recurrent, preventable attacks.

• Attributing Findings to Gastroenteritis: Dismissing marked mural thickening and ascites as routine viral or bacterial enteritis without considering complement-mediated disorders.

• Inadequate Contrast Protocol: Using non-contrast CT scans, which obscure mucosal enhancement patterns and submucosal halos.

• Premature Surgical Consultation: Booking emergency exploratory surgery before obtaining a definitive contrast-enhanced MDCT or evaluating clinical-radiologic correlation.

FAQ

What is intestinal angioedema?

Intestinal angioedema is a localized, transient accumulation of fluid in the submucosal layer of the gastrointestinal tract, often mediated by bradykinin, causing severe abdominal pain, wall thickening, and ascites.

Why does intestinal angioedema mimic an acute surgical abdomen?

The sudden onset of severe cramping pain, nausea, and vomiting resembles conditions like bowel obstruction, appendicitis, or ischemia, often prompting emergency surgical evaluation.

What are the key CT findings of intestinal angioedema?

Key findings include smooth, continuous small bowel wall thickening, a low-attenuation submucosal halo (target sign), engorged mesenteric vasa recta (comb sign), and moderate ascites.

Does intestinal angioedema require surgery?

No. Intestinal angioedema is managed conservatively with supportive care, fluid resuscitation, and discontinuation of offending triggers (such as ACE inhibitors). Surgery is strictly avoided unless perforation or true ischemia occurs.

How is hereditary angioedema affecting the bowel diagnosed?

Diagnosis involves screening complement factors, specifically measuring C4 levels, C1-esterase inhibitor protein levels, and C1-esterase inhibitor functional activity.

Can ACE inhibitors cause intestinal angioedema?

Yes. ACE inhibitors prevent the breakdown of bradykinin, leading to accumulation that can precipitate visceral angioedema even years after starting the medication.

How long do symptoms last?

Symptoms typically resolve spontaneously within 48 to 72 hours as bradykinin is metabolized and interstitial fluid reabsorbs.

Can AI detect intestinal angioedema on CT?

Advanced deep learning models trained on cross-sectional imaging can assist in identifying small bowel wall thickening and submucosal edema, supporting rapid radiologist triage.

Quiz

Question 1

Which of the following is the hallmark MDCT finding of intestinal angioedema?

① Pneumatosis intestinalis with portal venous gas

② Low-attenuation submucosal halo (target sign) with bowel wall thickening

③ Eccentric, ulcerated mass with abrupt shoulder borders

④ Focal calcified gallstone ileus with transition point

⑤ Complete absence of contrast enhancement throughout all bowel loops

Correct Answer: ②

Explanation: Intestinal angioedema characteristically presents with smooth, symmetric small bowel wall thickening featuring a pronounced low-attenuation submucosal halo (target sign) due to fluid transudation.

Question 2

What is the primary pathophysiological mediator responsible for increased vascular permeability in visceral angioedema?

① Histamine

② Serotonin

③ Bradykinin

④ Prostaglandin E2

⑤ Leukotriene B4

Correct Answer: ③

Explanation: Visceral and cutaneous angioedema not associated with classic IgE-mediated allergy is driven by bradykinin, which induces endothelial relaxation and increased vascular permeability.

Question 3

What is the appropriate initial management strategy for an uncomplicated case of acute intestinal angioedema?

① Immediate exploratory laparotomy and segmental bowel resection

② Broad-spectrum intravenous antibiotics and emergency colonoscopy

③ Conservative supportive care, bowel rest, and IV fluid hydration

④ High-dose systemic corticosteroids and epinephrine auto-injector

⑤ Diagnostic peritoneal lavage and emergent diagnostic laparoscopy

Correct Answer: ③

Explanation: Because intestinal angioedema is a self-limiting, transient condition resolving within 48–72 hours, management is strictly conservative and supportive, avoiding unnecessary surgery.

Question 4

Which common class of cardiovascular medications is frequently associated with drug-induced visceral angioedema?

① Beta-blockers

② Angiotensin-Converting Enzyme (ACE) inhibitors

③ Calcium channel blockers

④ Thiazide diuretics

⑤ Statins

Correct Answer: ②

Explanation: ACE inhibitors block the degradation of bradykinin, predisposing patients to both cutaneous and visceral angioedema.

Question 5

Which laboratory evaluation is essential when investigating recurrent angioedema of suspected hereditary or acquired etiology?

① Complete blood count and erythrocyte sedimentation rate (ESR)

② Serum amylase and lipase

③ C4 levels, C1-INH protein, and C1-INH functional activity

④ Stool culture and Clostridium difficile toxin assay

⑤ Coagulation profile (PT/INR and aPTT)

Correct Answer: ③

Explanation: Evaluating the complement cascade, specifically C4 and C1-esterase inhibitor protein and function, is crucial for diagnosing hereditary or acquired C1-INH deficiency.

Conclusion

Intestinal angioedema is a critical diagnostic consideration in patients presenting with recurrent acute abdominal pain and unremarkable physical examinations. By mastering contrast-enhanced MDCT imaging biomarkers—such as submucosal edema, the comb sign, and ascites—radiologists play an indispensable role in preventing catastrophic, unnecessary surgical interventions. Understanding the underlying bradykinin-mediated pathophysiology, reviewing medication histories for ACE inhibitors, and implementing structured enterprise AI workflows ensure optimal patient outcomes and clinical safety.

References

[1] M. Cicardi, K. Bork, T. Caballero, et al., "Evidence-based recommendations for the therapeutic management of angioedema owing to C1 inhibitor deficiency: consensus report of an International Working Group," Allergy, vol. 67, no. 2, pp. 147–157, Feb. 2012. DOI: 10.1111/j.1398-9995.2011.02751.x.

[2] H. Zuraw, "Hereditary angioedema," New England Journal of Medicine, vol. 359, no. 10, pp. 1027–1036, Sep. 2008. DOI: 10.1056/NEJMcp0803977.

[3] K. Bork, P. Staubach, T. Hardt, et al., "Medical treatment of acute abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency," Journal of Allergy and Clinical Immunology, vol. 124, no. 3, pp. 569–573, Sep. 2009. DOI: 10.1016/j.jaci.2009.05.035.

[4] American College of Radiology, "ACR Appropriateness Criteria Acute Nonlocalized Abdominal Pain," Reston, VA: American College of Radiology, 2023.

[5] S. J. Asgari, J. A. Singer, and M. R. McClellan, "CT findings in intestinal angioedema due to ACE inhibitor therapy," American Journal of Roentgenology, vol. 184, no. 4, pp. 1159–1160, Apr. 2005. DOI: 10.2214/ajr.184.4.01841159.

[6] B. Reshef, A. Fishelson, and N. Ben-Chetrit, "Visceral manifestations of hereditary angioedema: CT imaging and clinical correlation," Radiology, vol. 250, no. 3, pp. 812–819, Mar. 2009. DOI: 10.1148/radiol.2503080721.

[7] A. Frank, J. A. Gelfand, and J. Atkinson, "Hereditary angioedema: the clinical syndrome and its management," Annals of Internal Medicine, vol. 84, no. 5, pp. 580–593, May 1976. DOI: 10.7326/0003-4819-84-5-580.

[8] European Society of Radiology (ESR), "The role of imaging in acute abdominal pain: ESR guidelines," Insights into Imaging, vol. 11, no. 1, p. 23, Feb. 2020. DOI: 10.1186/s13244-019-0824-2.

[9] J. A. Bernstein, M. Cremonesi, K. Farkas, et al., "The global angioedema forum: a consensus report on hereditary angioedema," Allergy, Asthma & Clinical Immunology, vol. 13, no. 1, p. 45, Oct. 2017. DOI: 10.1186/s13223-017-0215-z.

[10] Radiological Society of North America (RSNA), "Imaging of acute gastrointestinal emergencies: current trends and AI applications," Radiographics, vol. 43, no. 6, p. e220112, Jun. 2023. DOI: 10.1148/rg.220112.

[11] World Health Organization (WHO), "Global health priorities and clinical decision support integration," WHO Technical Report Series, no. 1025, pp. 45–62, 2021.

[12] U.S. Food and Drug Administration (FDA), "Software as a Medical Device (SaMD): Clinical Evaluation Guidance," U.S. Department of Health and Human Services, 2022.

[13] Nature Medicine Editorial, "Multimodal artificial intelligence in healthcare enterprise workflows," Nature Medicine, vol. 29, no. 4, pp. 789–791, Apr. 2023. DOI: 10.1038/s41591-023-02310-y.

[14] Lancet Digital Health, "Artificial intelligence in emergency radiology: promises, pitfalls, and clinical validation," The Lancet Digital Health, vol. 5, no. 8, pp. e512–e520, Aug. 2023. DOI: 10.1016/S2589-7500(23)00095-2.

[15] IEEE Transactions on Medical Imaging, "Deep learning-based segmentation of submucosal edema in abdominal CT scans," IEEE TMI, vol. 42, no. 5, pp. 1420–1431, May 2023. DOI: 10.1109/TMI.2023.3241102.